By Thomas Anderson and Rotem Petranker — 2018
There is a growing research literature suggesting psychedelics hold incredible promise for treating mental health ailments ranging from depression and anxiety to PTSD. But how do we know for sure?
Read on theconversation.com
CLEAR ALL
Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).
1
The scientist talks to Laurence Phelan about fighting the establishment, battling preconceptions and breaking down egos.
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
How magic mushrooms expand consciousness.
2
As Buddhist teaching says, suffering has the potential to deepen our compassion and understanding of the human condition. And in so doing, it can lead us to even greater faith, joy and well-being.
It seems amazing that something so totally personal as ones level of consciousness could be considered an illegal act. But there is a turning of the tide both in policy and in scientific research, which has begun to recognise the value of these substances.
This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.